Heather Ann McSharry is Director at Jazz Pharmaceuticals plc (JAZZ). They have made 13 open-market trades across 1 company since 2015, most recently 2026-08-05.
CIK 0001576068
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JAZZ | 20,054 | $4.7M |
Shares reported on the most recent Form 4, priced at the 2026-08-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL | 2026-05-22 | 2026-05-27 | $241.00 | $482K | -2.0% | -2.7% | +10.0% |
| JAZZ | SELL | 2025-11-20 | 2025-11-24 | $177.78 | $1.2M | -6.4% | -5.8% | -4.4% |
| JAZZ | SELL | 2023-08-14 | 2023-08-15 | $138.16 | $371K | +1.5% | -3.8% | -12.3% |
| JAZZ | SELL | 2022-08-08 | 2022-08-09 | $153.91 | $1.2M | -0.7% | -3.9% | -7.8% |
| JAZZ | SELL | 2021-08-06 | 2021-08-10 | $147.96 | $418K | -7.6% | -7.0% | -7.7% |
| JAZZ | SELL | 2020-08-07 | 2020-08-10 | $125.87 | $254K | -2.0% | +10.9% | +15.0% |
| JAZZ | SELL | 2019-08-09 | 2019-08-12 | $135.65 | $214K | -3.2% | -1.3% | -3.1% |
| JAZZ | SELL | 2018-08-10 | 2018-08-13 | $176.61 | $253K | -3.5% | -5.6% | -15.5% |
| JAZZ | SELL | 2017-08-11 | 2017-08-14 | $142.36 | $204K | +2.7% | +5.7% | -5.5% |
| JAZZ | SELL | 2016-08-15 | 2016-08-17 | $136.45 | $93K | -7.5% | -8.0% | -18.0% |
| JAZZ | SELL | 2016-08-15 | 2016-08-17 | $136.45 | $93K | -7.5% | -8.0% | -18.0% |
| JAZZ | SELL | 2016-05-16 | 2016-05-17 | $145.20 | $202K | +1.8% | -2.4% | -7.6% |
| JAZZ | SELL | 2015-08-10 | 2015-08-11 | $179.99 | $156K | -10.8% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.